For diabetes patients, stopping GLP-1 drugs linked to doubled risk of heart attack, stroke, death

AI Summary

A new study found that people with type 2 diabetes who stopped GLP-1 treatment had twice the risk of heart attack, stroke, or death compared with those who continued treatment. The report highlights potential health risks associated with discontinuing the drugs.

People with type 2 diabetes who stopped GLP-1 treatment had twice the risk of heart attack, stroke or death than those who continued, according to a new study.